首页 > 市场调查报告书 > 製药

生物製剂分子标靶治疗学

2030 年亚太地区抗体发现市场预测 - 区域分析 - 按抗体类型、性质、服务和最终用户

市场调查报告书

商品编码

1592593

2030 年亚太地区抗体发现市场预测 - 区域分析 - 按抗体类型、性质、服务和最终用户

Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 90 Pages | 订单完成后即时交付

价格

简介目录图表

2022年亚太地区抗体发现市值为65896505万美元，预计2030年将达到115868186万美元；预计2022年至2030年复合年增长率为7.3%。

发展中地区生物技术产业的激增推动亚太抗体发现市场

抗体在辨识抗原方面具有极高的精确度，使其成为科学家和临床医生的宝贵工具。在现代生物技术中，从基础研究到创新医学评估的许多过程都需要抗体。治疗性抗体的开发为治疗各种疾病开闢了新途径，证明了这些颗粒的转化能力。抗体在基于抗体的诊断中也至关重要，因为它们提供了准确可靠的疾病识别方法。政府不断增加的支持、公私合作伙伴关係的加强、疾病概况的不断变化以及资助活动的增加正在广泛提高亚太地区等地区生物技术行业的绩效。

根据经济合作暨发展组织 (OECD) 的数据，截至 2019 年，中国在研发支出方面处于领先地位。亚洲等地区国家政府提供税收优惠、更便宜的土地和直接投资，鼓励生技公司扩大产能和增强能力。因此，台湾、马来西亚、印度、中国、新加坡和日本等国家是生技产业最有利的目的地之一。此外，这些亚洲国家更注重利用基因组学、蛋白质组学和生物标记的进步进行诊断和治疗应用。因此，发展中地区生物技术产业的持续扩散预计将在未来几年为抗体发现市场创造机会。

亚太地区抗体发现市场概况

亚太地区抗体发现市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。 2022年，中国将占据最大的市场份额，而印度预计在预测期内将实现显着的市场复合年增长率。中国的生物製药产业正在经历巨大转变，从以仿製药为中心的格局演变为蓬勃发展的创新中心。此外，工业化的进步以及新药、高端医疗器材和技术的应用也有助于中国抗体发现市场的成长。

中国正在经历心血管疾病和其他慢性病的盛行率激增。根据《生物医学与环境科学期刊》报道，2021年中国有近3.3亿人患有心血管疾病。因此，心臟病的迅速流行引发了对抗体发现的需求。在研究中心的帮助下，可以研究抗体序列，开发新的和新颖的抗体，并优化现有的抗体。根据 Scimago Institute 排名，截至 2022 年，中国拥有近 170 个医学研究中心，其次是日本（72 个）、澳洲（53 个）和印度（17 个）。此外，越来越多的市场参与者专注于亚太地区国家的地理扩张和其他成长策略、研究中心数量的增加以及政府资助的显着增加，推动了亚太地区抗体发现市场的成长。

亚太地区抗体发现市场收入及 2030 年预测（十亿美元）

亚太地区抗体发现市场区隔

亚太地区抗体发现市场按抗体类型、性质、服务、最终用户和国家分类。

根据抗体类型，亚太地区抗体发现市场分为单株抗体、多株抗体等。 2022 年，单株抗体领域占据亚太地区最大的抗体发现市场。

就性质而言，亚太地区抗体发现市场分为人类和人源化、嵌合和鼠类。 2022 年，人类和人源化细分市场占据亚太地区最大的抗体发现市场。

依服务划分，亚太抗体发现市场分为噬菌体展示、杂交瘤、基因改造动物、单细胞和酵母展示。 2022 年，噬菌体展示领域占据亚太地区最大的抗体发现市场。

根据最终用户，亚太地区抗体发现市场分为製药和生技公司、研究实验室等。 2022 年，製药和生物技术公司细分市场占据亚太地区最大的抗体发现市场。

依国家/地区划分，亚太地区抗体发现市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。 2022年，中国在亚太抗体发现市场份额中占据主导地位。

Charles River Laboratories International Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals 北京有限公司是亚太地区抗体发现市场上的一些领先公司。

The remarkable precision of antibodies in identifying antigens makes them invaluable tools for scientists and clinicians. In modern biotechnology, antibodies are required in numerous processes, from basic research to innovative medical evaluations. The development of therapeutic antibodies has opened new avenues in treating various diseases, demonstrating the transformative ability of these particles. Antibodies are also crucial in antibody-based diagnostics as they provide accurate and reliable approaches to disease identification. Growing support from governments, rising public-private partnerships, continuously changing disease profiles, and increasing funding activities are widely enhancing the performance of biotechnology industries in the regions such as Asia Pacific.

As per the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure as of 2019. Heavy investments encourage the adoption of advanced technologies in the healthcare sector. Governments of countries in regions such as Asia offer tax incentives, cheaper land, and direct investments for encouraging biotechnology companies to expand their capacities and strengthen their capabilities. Thus, countries such as Taiwan, Malaysia, India, China, Singapore, and Japan are among the most advantageous destinations for the biotechnology industries. Furthermore, these Asian countries are more focused on using genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing proliferation of biotechnology industries in developing regions is expected to create opportunities for the antibody discovery market in the coming years.

Asia Pacific Antibody Discovery Market Overview

The Asia Pacific antibody discovery market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China accounted for the largest share of the market in 2022, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generics-focused landscape to a thriving innovation hub. Additionally, progress in industrialization, and the application of novel drugs, high-end medical devices, and techniques contribute to the antibody discovery market growth in China.

China is experiencing an upsurge in the prevalence of cardiovascular disease and other chronic diseases. According to the Journal of Biomedical and Environmental Science, nearly 330 million people from the country suffered from cardiovascular diseases in 2021. Antibody products are crucial for the development of novel therapeutics against cardiovascular diseases. Therefore, a burgeoning prevalence of heart disease triggers the need for antibody discovery. With the help of research centers, antibody sequences can be researched, new and novel antibodies can be developed, and existing antibodies can be optimized. According to the Scimago Institute Ranking, China had nearly 170 medical research centers as of 2022, followed by Japan (72), Australia (53), and India (17). Further, the growing number of market players focusing on countries in Asia Pacific for their geographic expansion and other growth strategies, the rising count of research centers, and a notable increase in government funding fuel the antibody discovery market growth in Asia Pacific.

Asia Pacific Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Asia Pacific Antibody Discovery Market Segmentation

The Asia Pacific antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Asia Pacific antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Asia Pacific antibody discovery market share in 2022.

In terms of nature, the Asia Pacific antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Asia Pacific antibody discovery market share in 2022.

By services, the Asia Pacific antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on end user, the Asia Pacific antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Asia Pacific antibody discovery market share in 2022.

Based on country, the Asia Pacific antibody discovery market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific antibody discovery market share in 2022.

Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Asia Pacific antibody discovery market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Antibody Discovery Market - Key Market Dynamics

4.1 Asia Pacific Antibody Discovery Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Investments in Research & Development
- 4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
- 4.3.1 High Cost of Production
4.4 Market Opportunities
- 4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
- 4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Asia Pacific Market Analysis

5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Asia Pacific Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Antibody Discovery Market - Country Analysis

10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
- 10.1.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 China
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Japan
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 India
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.4 Australia
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.5 South Korea
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.6 Rest of Asia Pacific
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 BioDuro LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sartorius AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Twist Bioscience Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market